SPF/UV Filters

Sunscreen Innovation Act Passes House and Moves to President

Nov 18, 2014

New U.S. sunscreen actives are potentially within reach, as the The Sunscreen Innovation Act (S. 2141) by passed the U.S. House of Representatives and will be sent to President Barack Obama for his signature and enactment into law.

BASF Micronized UV Filter Added to Annex VI of EU Cosmetics Regulation

Aug 20, 2014

BASF's Tinosorb A2B (INCI: Tris-biphenyl Triazine) has been added to Annex VI (the positive list) of the EU Cosmetics Regulation (EC) No. 1223/2009.

Sunscreen Innovation Act Passes House and Moves to Senate

Jul 30, 2014

New sunscreen actives may finally be on their way in the United States, as the Sunscreen Innovation Act (H.R.4250) passed the House of Representatives on July 28, 2014. The bill now goes to the Senate with the cosmetics industry eager to have it pushed through.

Sunscreen Regulations: Why 'Final' is Not the Right Word

May 6, 2014Robert Ross-Fichtner, Focal Point Research Inc.

Over the past 25 years, no category of “cosmetics” has seen change like sunscreens. This discussion reviews how current regulations have come to be, and looks to where they are headed.

PASS Coalition Supports Move to Speed Approval of New UV Filters, Looks to Canada

Apr 14, 2014

In March 2014, the PASS Coalition published its support of a proposed Act to potentially speed the FDA's approval of new UV filters. In a related blog post, PASS followers congratulated those involved, and urged Canadian regulators to do the same.

Sunscreen Innovation Act Introduced into Congress to Amend FDA's TEA Program

Mar 18, 2014

On Mar. 13, 2014, U.S. Senator Jack Reed (D-RI) and U.S. Congressman Ed Whitfield (R-KY) introduced the bipartisan, bicameral Sunscreen Innovation Act (S. 2141 and H.R. 4250, respectively), which has been supported by the Public Access to SunScreen (PASS) Coalition.

FDA Publishes Opinion on Two Sunscreen TEAs and Is Urged for More Action by PASS

Mar 4, 2014

The end of February was busy for the U.S. Food and Drug Administration (FDA), which published two letters on the Time and Extent Applications (TEAs) for diethylhexyl butamido triazone (Uvasorb HEB) and amiloxate (Neo Heliopan E 1000), finding insufficient scientific evidence to claim either as generally recognized as safe and effective (GRASE) and denying their addition to the OTC Sunscreen Monograph.